http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Abbott (ABT), Tandem Diabetes Care (TNDM) Exploring New Integrated Solutions to Improve Diabetes Management
-
Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
-
Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
-
Late-Breaking Data Shows Abbott's MitraClip™ is Cost Effective, Increases Life Expectancy and Improves Quality of Life
-
New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves
-
Absolute Announces Renewal of Share Buyback Program
-
Abbott (ABT) Announces FDA Approves its "Low Dose," Recharge-Free Spinal Cord Stimulation System for People Living with Chronic Pain
-
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
-
Abbott (ABT) Announces FDA Clears its High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks
-
U.S. FDA Clears Abbott's High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks Faster and More Accurately
-
Abbott Hosts Conference Call for Third-Quarter Earnings
-
Abbott (ABT) Announces European Approval of Two Life-saving Heart Devices for Babies and Children
-
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
-
Abbott Named the Industry Leader in Sustainability for the Seventh Consecutive Year on the Dow Jones Sustainability Index (DJSI)
-
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Delivery Technologies to Help Change the Way Diabetes is Managed
-
Sanof (SNY), Abbott (ABT) Partner to Integrate Glucose Sensing and Insulin Delivery Technologies
-
Abbott's Revolutionary FreeStyle® Libre System Now Reimbursed in the Two Largest Provinces in Canada
-
Abbott Declares 383rd Consecutive Quarterly Dividend
-
Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack
-
Ministry of Health of Rwanda, Society for Family Health Rwanda and Abbott Launch Pioneering Model of Primary Health Care Service Delivery in Rwanda
-
He's Back and He's Hydrated: Abbott and NFL Star Odell Beckham Jr. Partner for Pedialyte®
-
Abbott Launches World's First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves
-
New Study Finds Abbott's Blood Test Technology Could Help Detect Brain Injury Quickly, Even if CT Scan is Normal
-
Together, We Can Increase the Number of Women in STEM: Here is a Tool to Help Companies Get Started
-
Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing
-
Absolute Reports Fiscal 2019 Fourth Quarter and Annual Financial Results
-
Absolute Names Lynn Atchison to Board of Directors
-
Absolute Declares Quarterly Dividend
-
Abbott Reports Second-Quarter 2019 Results
-
Abbott (ABT) Receives U.S. Approval of Next-Generation MitraClip
-
Abbott Receives U.S. Approval of Next-Generation MitraClip®, Bringing New Enhancements to Abbott's Leading MitraClip Platform
-
Abbott (ABT) Reports FDA Approval of Alinity s System
-
Abbott Announces FDA Approval of the Alinity™ s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
-
Nutrition Is the Missing Ingredient in Home Health Today, New Study Shows
-
Abbott Hosts Conference Call for Second-Quarter Earnings
-
CARE, Abbott and the Abbott Fund Launch Partnership to Address Noncommunicable Diseases (NCDs) in Humanitarian Settings
-
Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
-
Abbott Declares 382ⁿᵈ Consecutive Quarterly Dividend
-
New Survey Shows Millennials Can Help Avoid Blood Shortages
-
New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes
-
Absolute Strengthens Executive Team to Accelerate Next Stage of Growth
-
TRILUMINATE Study Shows Treatment with Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks
-
New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results
-
Nearly 9 out of 10 College Students with Student Debt Say It's Important to Find a Company That Offers Loan Relief
-
Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders
-
Abbott to Present at UBS Global Healthcare Conference
-
Absolute Reports Fiscal 2019 Third Quarter Financial Results
-
Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
-
Abbott (ABT) Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
-
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test

